Retour

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

News Conference Calls/ Webcasts

DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).

GlobeNewswire Inc. • 29/04/2024 à 22:30:00
Eton Pharmaceutcials, Inc. Common Stock
Address: 21925 W. FIELD PARKWAY
Postal Code: 60010-7278
City: DEER PARK
State: IL
Phone Number: (847) 787-7361
Website: https://www.etonpharma.com
Status: Active
Company Info

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

List Date2018-11-14
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001710340
Composite figiBBG00H0KCMV1
Share Class figiBBG00H0KCMW0
Market Cap88,110,053 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees30
Share Class Shares Outstanding25690000
Weighted Shares Outstanding25688062
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
3.641
3.48
3.585
3.444
3.991
Variance
-0.44%
-2.82%
4.06%
-13.03%
6.65%
Open
3.657
3.581
3.445
3.96
3.742
Highest
3.795
3.755
3.645
3.96
4.11
Lowest
3.795
3.747
3.645
3.811
4.11
History
PeriodVarhighestlowest
1 week
-2.73%
4.11
3.645
1 month
4.06%
3.498
3.253
3 month
-19.11%
4.57
3.253
6 month
-1.62%
3.7194
3.253
1 year
4%
3.6
2.42
3 year
-55.72%
8.4
1.95
5 year
-56.14%
8.34
1.95
10 year
-43.04%
6.65
1.95
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Assets 23,928,000 30,932,000 31,526,000 UNPUB
Current Assets 19,118,000 26,333,000 27,157,000 UNPUB
Current Liabilities 7,494,000 9,588,000 10,393,000 UNPUB
Equity 11,241,000 16,725,000 16,892,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 11,241,000 16,725,000 16,892,000 UNPUB
Liabilities 12,687,000 14,207,000 14,634,000 UNPUB
Liabilities And Equity 23,928,000 30,932,000 31,526,000 UNPUB
Noncurrent Assets 4,810,000 4,599,000 4,369,000 UNPUB
Noncurrent Liabilities 5,193,000 4,619,000 4,241,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 UNPUB
Net Cash Flow, Continuing 0 0 0 UNPUB
Net Cash Flow From Financing Activities -49,000 -246,000 -368,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -49,000 -246,000 -368,000 UNPUB
Net Cash Flow From Investing Activities 1,597,000 -6,857,000 -505,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 1,597,000 -6,857,000 -505,000 UNPUB
Net Cash Flow From Operating Activities -1,548,000 7,103,000 873,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -1,548,000 7,103,000 873,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Comprehensive Income/Loss -2,660,000 4,559,000 -579,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -2,660,000 4,559,000 -579,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Basic Earnings Per Share -100 0 0 UNPUB
Benefits Costs and Expenses 7,964,000 7,438,000 7,607,000 UNPUB
Cost Of Revenue 1,958,000 2,315,000 2,625,000 UNPUB
Costs And Expenses 7,964,000 7,438,000 7,607,000 UNPUB
Diluted Earnings Per Share UNPUB 0 0 UNPUB
Gross Profit 3,346,000 9,682,000 4,403,000 UNPUB
Income/Loss From Continuing Operations After Tax -2,660,000 4,559,000 -579,000 UNPUB
Income/Loss From Continuing Operations Before Tax -2,660,000 4,559,000 -579,000 UNPUB
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating 265,000 273,000 805,000 UNPUB
Net Income/Loss -2,660,000 4,559,000 -579,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -2,660,000 4,559,000 -579,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -2,660,000 4,559,000 -579,000 UNPUB
Operating Expenses 5,880,000 5,799,000 4,951,000 UNPUB
Operating Income/Loss -2,534,000 3,883,000 -548,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 5,304,000 11,997,000 7,028,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-16
Assets 23,196,000 23,046,000 21,520,000 25,030,000
Current Assets 18,751,000 19,776,000 16,420,000 20,004,000
Current Liabilities 3,482,000 3,812,000 4,661,000 6,461,000
Equity 13,383,000 13,242,000 11,181,000 13,078,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 13,383,000 13,242,000 11,181,000 13,078,000
Liabilities 9,813,000 9,804,000 10,339,000 11,952,000
Liabilities And Equity 23,196,000 23,046,000 21,520,000 25,030,000
Noncurrent Assets 4,445,000 3,270,000 5,100,000 5,026,000
Noncurrent Liabilities 0 0 5,678,000 5,491,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 2,640,000 -3,668,000 1,899,000
Net Cash Flow, Continuing 0 2,640,000 -3,668,000 1,899,000
Net Cash Flow From Financing Activities -385,000 117,000 35,000 -134,000
Net Cash Flow From Financing Activities, Continuing -385,000 117,000 35,000 -134,000
Net Cash Flow From Investing Activities -838,000 62,000 -2,000,000 -2,788,000
Net Cash Flow From Investing Activities, Continuing -838,000 62,000 -2,000,000 -2,788,000
Net Cash Flow From Operating Activities 1,223,000 2,461,000 -1,703,000 4,821,000
Net Cash Flow From Operating Activities, Continuing 1,223,000 2,461,000 -1,703,000 4,821,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-16
Comprehensive Income/Loss -5,330,000 -1,558,000 -3,045,000 -9,021,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -5,330,000 -1,558,000 -3,045,000 -9,021,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-16
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 7,506,000 8,916,000 6,264,000 30,272,000
Cost Of Revenue 718,000 2,745,000 1,201,000 6,933,000
Costs And Expenses 7,506,000 8,916,000 6,264,000 30,272,000
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 1,458,000 4,613,000 2,018,000 14,318,000
Income/Loss From Continuing Operations After Tax -5,330,000 -1,558,000 -3,045,000 -9,021,000
Income/Loss From Continuing Operations Before Tax -5,330,000 -1,558,000 -3,045,000 -9,021,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 247,000 219,000 233,000 955,000
Net Income/Loss -5,330,000 -1,558,000 -3,045,000 -9,021,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -5,330,000 -1,558,000 -3,045,000 -9,021,000
Net Income/Loss Available To Common Stockholders, Basic -5,330,000 -1,558,000 -3,045,000 -9,021,000
Operating Expenses 6,545,000 5,953,000 4,913,000 22,578,000
Operating Income/Loss -5,087,000 -1,340,000 -2,895,000 -8,260,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 2,176,000 7,358,000 3,219,000 21,251,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-16 2022-03-16
Assets 31,186,000 29,906,000 26,606,000 27,465,000
Current Assets 30,274,000 29,075,000 25,863,000 23,604,000
Current Liabilities 3,199,000 3,106,000 5,360,000 4,558,000
Equity 21,555,000 20,736,000 15,660,000 17,630,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 21,555,000 20,736,000 15,660,000 17,630,000
Liabilities 9,631,000 9,170,000 10,946,000 9,835,000
Liabilities And Equity 31,186,000 29,906,000 26,606,000 27,465,000
Noncurrent Assets 912,000 831,000 743,000 3,861,000
Noncurrent Liabilities 0 0 5,586,000 5,277,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-16 2022-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 4,507,000 -3,093,000 -6,889,000
Net Cash Flow, Continuing 0 4,507,000 -3,093,000 -6,889,000
Net Cash Flow From Financing Activities 103,000 361,000 -141,000 391,000
Net Cash Flow From Financing Activities, Continuing 103,000 361,000 -141,000 391,000
Net Cash Flow From Investing Activities -3,818,000 4,515,000 -2,000 -2,559,000
Net Cash Flow From Investing Activities, Continuing -3,818,000 4,515,000 -2,000 -2,559,000
Net Cash Flow From Operating Activities 3,715,000 -369,000 -2,950,000 -4,721,000
Net Cash Flow From Operating Activities, Continuing 3,715,000 -369,000 -2,950,000 -4,721,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-16 2022-03-16
Comprehensive Income/Loss 5,116,000 -2,016,000 -6,094,000 -1,955,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 5,116,000 -2,016,000 -6,094,000 -1,955,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-16 2022-03-16
Basic Earnings Per Share 0 0 UNPUB UNPUB
Benefits Costs and Expenses 6,781,000 5,083,000 6,869,000 23,787,000
Cost Of Revenue 1,590,000 136,000 617,000 2,623,000
Costs And Expenses 6,781,000 5,083,000 6,869,000 23,787,000
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit 10,307,000 2,931,000 158,000 19,209,000
Income/Loss From Continuing Operations After Tax 5,116,000 -2,016,000 -6,094,000 -1,955,000
Income/Loss From Continuing Operations Before Tax 5,116,000 -2,016,000 -6,094,000 -1,955,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 264,000 249,000 253,000 1,042,000
Net Income/Loss 5,116,000 -2,016,000 -6,094,000 -1,955,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 5,116,000 -2,016,000 -6,094,000 -1,955,000
Net Income/Loss Available To Common Stockholders, Basic 5,116,000 -2,016,000 -6,094,000 -1,955,000
Operating Expenses 4,944,000 5,256,000 6,005,000 20,704,000
Operating Income/Loss 5,363,000 -2,325,000 -5,847,000 -1,495,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 11,897,000 3,067,000 775,000 21,832,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-12 2020-11-12 2021-03-16
Assets 17,241,000 14,559,000 11,395,000 26,319,000
Current Assets 15,341,000 12,823,000 9,785,000 24,701,000
Current Liabilities 2,051,000 2,739,000 3,219,000 3,794,000
Equity 10,620,000 7,031,000 1,388,000 15,663,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 10,620,000 7,031,000 1,388,000 15,663,000
Liabilities 6,621,000 7,528,000 10,007,000 10,656,000
Liabilities And Equity 17,241,000 14,559,000 11,395,000 26,319,000
Noncurrent Assets 1,900,000 1,736,000 1,610,000 1,618,000
Noncurrent Liabilities 0 0 6,788,000 6,862,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-12 2020-11-12 2021-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 9,229,000
Net Cash Flow, Continuing 0 0 0 9,229,000
Net Cash Flow From Financing Activities 7,490,000 788,000 2,158,000 31,625,000
Net Cash Flow From Financing Activities, Continuing 7,490,000 788,000 2,158,000 31,625,000
Net Cash Flow From Investing Activities -273,000 2,065,000 2,936,000 -50,000
Net Cash Flow From Investing Activities, Continuing -273,000 2,065,000 2,936,000 -50,000
Net Cash Flow From Operating Activities -7,217,000 -2,853,000 -5,094,000 -22,346,000
Net Cash Flow From Operating Activities, Continuing -7,217,000 -2,853,000 -5,094,000 -22,346,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-12 2020-11-12 2021-03-16
Comprehensive Income/Loss -9,049,000 -4,730,000 -6,504,000 -27,970,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -9,049,000 -4,730,000 -6,504,000 -27,970,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-12 2020-11-12 2021-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 9,148,000 4,722,000 6,487,000 28,009,000
Cost Of Revenue 102,000 28,000 -116,000 286,000
Costs And Expenses 9,148,000 4,530,000 6,255,000 28,009,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit -3,000 -8,000 -17,000 -247,000
Income/Loss From Continuing Operations After Tax -9,049,000 -4,730,000 -6,504,000 -27,970,000
Income/Loss From Continuing Operations Before Tax -9,049,000 -4,730,000 -6,504,000 -27,970,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 195,000 191,000 231,000 884,000
Net Income/Loss -9,049,000 -4,730,000 -6,504,000 -27,970,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -9,049,000 -4,730,000 -6,504,000 -27,970,000
Net Income/Loss Available To Common Stockholders, Basic -9,049,000 -4,730,000 -6,504,000 -27,970,000
Operating Expenses 8,878,000 4,530,000 6,255,000 26,864,000
Operating Income/Loss -8,881,000 -4,538,000 -6,272,000 -27,111,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 99,000 -8,000 -17,000 39,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-14 2020-03-05
Assets 23,017,000 18,244,000 13,507,000 17,072,000
Current Assets 21,527,000 16,755,000 12,107,000 15,009,000
Current Liabilities 3,656,000 1,459,000 1,107,000 1,963,000
Equity 19,242,000 16,699,000 12,348,000 10,550,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 19,242,000 16,699,000 12,348,000 10,550,000
Liabilities 3,775,000 1,545,000 1,159,000 6,522,000
Liabilities And Equity 23,017,000 18,244,000 13,507,000 17,072,000
Noncurrent Assets 1,490,000 1,489,000 1,400,000 2,063,000
Noncurrent Liabilities 0 0 52,000 4,559,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-14 2020-03-05
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -7,151,000 7,151,000 0 -14,669,000
Net Cash Flow, Continuing -7,151,000 7,151,000 0 -14,669,000
Net Cash Flow From Financing Activities 4,000 201,000 77,000 5,203,000
Net Cash Flow From Financing Activities, Continuing 4,000 201,000 77,000 5,203,000
Net Cash Flow From Investing Activities -388,000 11,146,000 3,138,000 -1,846,000
Net Cash Flow From Investing Activities, Continuing -388,000 11,146,000 3,138,000 -1,846,000
Net Cash Flow From Operating Activities -6,767,000 -4,196,000 -3,215,000 -18,026,000
Net Cash Flow From Operating Activities, Continuing -6,767,000 -4,196,000 -3,215,000 -18,026,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-14 2020-03-05
Comprehensive Income/Loss -7,410,000 -3,249,000 -4,965,000 -18,320,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,410,000 -3,249,000 -4,965,000 -18,320,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-14 2020-03-05
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 7,910,000 3,249,000 4,965,000 19,279,000
Cost Of Revenue UNPUB UNPUB UNPUB 453,000
Costs And Expenses 7,910,000 3,249,000 4,965,000 19,279,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB 506,000
Income/Loss From Continuing Operations After Tax -7,410,000 -3,249,000 -4,965,000 -18,320,000
Income/Loss From Continuing Operations Before Tax -7,410,000 -3,249,000 -4,965,000 -18,320,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -7,410,000 -3,249,000 -4,965,000 -18,320,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,410,000 -3,249,000 -4,965,000 -18,320,000
Net Income/Loss Available To Common Stockholders, Basic -7,410,000 -3,249,000 -4,965,000 -18,320,000
Operating Expenses 8,054,000 3,349,000 5,042,000 19,107,000
Operating Income/Loss -7,554,000 -3,349,000 -5,042,000 -18,601,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 500,000 0 0 959,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-25
Assets UNPUB UNPUB UNPUB 28,327,000
Current Assets UNPUB UNPUB UNPUB 27,502,000
Current Liabilities UNPUB UNPUB UNPUB 2,024,000
Equity UNPUB UNPUB UNPUB 26,303,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 26,303,000
Liabilities UNPUB UNPUB UNPUB 2,024,000
Liabilities And Equity UNPUB UNPUB UNPUB 28,327,000
Noncurrent Assets UNPUB UNPUB UNPUB 825,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-25
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB 13,579,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 13,579,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 21,960,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 21,960,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -236,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -236,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -8,145,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -8,145,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-25
Comprehensive Income/Loss UNPUB UNPUB UNPUB -12,740,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -12,740,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-25
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -12,740,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -12,740,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB UNPUB -12,740,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -12,740,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -37,229,000
Operating Expenses UNPUB UNPUB UNPUB 10,321,000
Operating Income/Loss UNPUB UNPUB UNPUB -10,321,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 24,489,000
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 24,489,000
Revenues UNPUB UNPUB UNPUB 0
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
★
16:30
United States
3331000000000.000
★★
16:30
United States
7353000000000.000
★
15:50
United States
★★
11:30
United States
★
11:30
United States
5.275
★
11:30
United States
5.270
★
11:30
United States
★
11:30
United States
★★
10:30
United States
★
10:30
United States
MAY 10
70000000000.000
79000000000.000
76000000000.000
★
10:30
United States
MAY 10
★★
10:00
United States
★
09:15
United States
APR
-0.300
0.200
0.100
★★
09:15
United States
APR
-0.380
0.090
★
09:15
United States
APR
78.400
78.500
78.400
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:ETON240419P00007500 OPASPS Put American 100 7.5 EMLD 2024-04-19
O:ETON240419P00005000 OPASPS Put American 100 5 EMLD 2024-04-19
O:ETON240419P00002500 OPASPS Put American 100 2.5 EMLD 2024-04-19
O:ETON240419C00007500 OCASPS Call American 100 7.5 EMLD 2024-04-19
O:ETON240419C00005000 OCASPS Call American 100 5 EMLD 2024-04-19
O:ETON240419C00002500 OCASPS Call American 100 2.5 EMLD 2024-04-19
O:ETON240315P00007500 OPASPS Put American 100 7.5 EMLD 2024-03-15
O:ETON240315P00005000 OPASPS Put American 100 5 EMLD 2024-03-15
O:ETON240315P00002500 OPASPS Put American 100 2.5 EMLD 2024-03-15
O:ETON240315C00007500 OCASPS Call American 100 7.5 EMLD 2024-03-15
O:ETON240315C00005000 OCASPS Call American 100 5 EMLD 2024-03-15
O:ETON240315C00002500 OCASPS Call American 100 2.5 EMLD 2024-03-15
O:ETON240216P00010000 OPASPS Put American 100 10 EMLD 2024-02-16
O:ETON240216C00010000 OCASPS Call American 100 10 EMLD 2024-02-16
O:ETON240216P00007500 OPASPS Put American 100 7.5 EMLD 2024-02-16
O:ETON240216P00005000 OPASPS Put American 100 5 EMLD 2024-02-16
O:ETON240216P00002500 OPASPS Put American 100 2.5 EMLD 2024-02-16
O:ETON240216C00007500 OCASPS Call American 100 7.5 EMLD 2024-02-16
O:ETON240216C00005000 OCASPS Call American 100 5 EMLD 2024-02-16
O:ETON240216C00002500 OCASPS Call American 100 2.5 EMLD 2024-02-16
O:ETON240119P00007500 OPASPS Put American 100 7.5 EMLD 2024-01-19
O:ETON240119P00005000 OPASPS Put American 100 5 EMLD 2024-01-19
O:ETON240119P00002500 OPASPS Put American 100 2.5 EMLD 2024-01-19
O:ETON240119C00007500 OCASPS Call American 100 7.5 EMLD 2024-01-19
O:ETON240119C00005000 OCASPS Call American 100 5 EMLD 2024-01-19
O:ETON240119C00002500 OCASPS Call American 100 2.5 EMLD 2024-01-19
O:ETON231215P00007500 OPASPS Put American 100 7.5 EMLD 2023-12-15
O:ETON231215P00005000 OPASPS Put American 100 5 EMLD 2023-12-15
O:ETON231215P00002500 OPASPS Put American 100 2.5 EMLD 2023-12-15
O:ETON231215C00007500 OCASPS Call American 100 7.5 EMLD 2023-12-15
O:ETON231215C00005000 OCASPS Call American 100 5 EMLD 2023-12-15
O:ETON231215C00002500 OCASPS Call American 100 2.5 EMLD 2023-12-15
O:ETON231117P00010000 OPASPS Put American 100 10 EMLD 2023-11-17
O:ETON231117C00010000 OCASPS Call American 100 10 EMLD 2023-11-17
O:ETON231117P00007500 OPASPS Put American 100 7.5 EMLD 2023-11-17
O:ETON231117P00005000 OPASPS Put American 100 5 EMLD 2023-11-17
O:ETON231117P00002500 OPASPS Put American 100 2.5 EMLD 2023-11-17
O:ETON231117C00007500 OCASPS Call American 100 7.5 EMLD 2023-11-17
O:ETON231117C00005000 OCASPS Call American 100 5 EMLD 2023-11-17
O:ETON231117C00002500 OCASPS Call American 100 2.5 EMLD 2023-11-17
O:ETON231020P00010000 OPASPS Put American 100 10 EMLD 2023-10-20
O:ETON231020P00007500 OPASPS Put American 100 7.5 EMLD 2023-10-20
O:ETON231020P00005000 OPASPS Put American 100 5 EMLD 2023-10-20
O:ETON231020P00002500 OPASPS Put American 100 2.5 EMLD 2023-10-20
O:ETON231020C00010000 OCASPS Call American 100 10 EMLD 2023-10-20
O:ETON231020C00007500 OCASPS Call American 100 7.5 EMLD 2023-10-20
O:ETON231020C00005000 OCASPS Call American 100 5 EMLD 2023-10-20
O:ETON231020C00002500 OCASPS Call American 100 2.5 EMLD 2023-10-20
O:ETON230915P00005000 OPASPS Put American 100 5 EMLD 2023-09-15
O:ETON230915P00002500 OPASPS Put American 100 2.5 EMLD 2023-09-15
O:ETON230915C00005000 OCASPS Call American 100 5 EMLD 2023-09-15
O:ETON230915C00002500 OCASPS Call American 100 2.5 EMLD 2023-09-15
O:ETON230915P00010000 OPASPS Put American 100 10 EMLD 2023-09-15
O:ETON230915P00007500 OPASPS Put American 100 7.5 EMLD 2023-09-15
O:ETON230915C00010000 OCASPS Call American 100 10 EMLD 2023-09-15
O:ETON230915C00007500 OCASPS Call American 100 7.5 EMLD 2023-09-15
O:ETON230818P00007500 OPASPS Put American 100 7.5 EMLD 2023-08-18
O:ETON230818P00005000 OPASPS Put American 100 5 EMLD 2023-08-18
O:ETON230818P00002500 OPASPS Put American 100 2.5 EMLD 2023-08-18
O:ETON230818C00007500 OCASPS Call American 100 7.5 EMLD 2023-08-18
O:ETON230818C00005000 OCASPS Call American 100 5 EMLD 2023-08-18
O:ETON230818C00002500 OCASPS Call American 100 2.5 EMLD 2023-08-18
News Stream
Stocks Earnings Releases and Operating Results
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
•  Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth•  Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400•  Management to hold conference call today at 4:30pm ET
GlobeNewswire Inc. • 6d ago
Calendar Calendar of Events
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that Sean Brynjelsen, Chief Executive Officer, and James Gruber, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference in New York as follows:
GlobeNewswire Inc. • 2w ago
Health Health
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Company anticipates 10-month review for potential approval in Q1 2025 -- Eton expects ET-400 and Alkindi Sprinkle® to achieve potential combined peak sales of more than $50 million annually -- Product has patent protection through 2043 -
GlobeNewswire Inc. • 2w ago
News Conference Calls/ Webcasts
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).
GlobeNewswire Inc. • 2w ago
Stocks Mergers and Acquisitions
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. rights to PKU GOLIKE® from RELIEF THERAPEUTICS Holding SA (“Relief”) (SIX: RLF, OTCQB: RLFTF, RLFTY).
GlobeNewswire Inc. • 1mo ago
News News
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -125% and 5.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 2mo ago
Stocks Earnings Releases and Operating Results
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
DEER PARK, Ill., March 14, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter and year ended December 31, 2023.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
DEER PARK, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report fourth quarter and full year 2023 financial results on Thursday, March 14, 2024. Management will host a conference call and live audio webcast to discuss these results at 4:30 p.m. ET (3:30 p.m. CT).
GlobeNewswire Inc. • 2mo ago
News Contests/Awards
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
DEER PARK, Ill., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the United States Patent and Trademark Office (“USPTO”) has granted the Company’s U.S. Patent Application No. 18/113,458, which covers the Company’s ET-400 product candidate’s proprietary formulation of oral liquid hydrocortisone. The patent has an expiration in 2043 and is expected to be listed in the FDA’s Orange Book upon the product’s approval. The Company has additional patent applications related to the product under review with the USPTO.
GlobeNewswire Inc. • 2mo ago
Health Health
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
-- Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* ---- Current Nitisinone market is estimated to exceed $50 million annually ---- Product is now available exclusively through Optime Care -- DEER PARK, Ill., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing, acquiring, and commercializing products to address unmet needs in patients suffering from rare diseases, today announced the commercial availability of Nitisinone Capsules for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine. Please see important safety information below. Tyrosinemia type 1 is an ultra-rare condition that is estimated to impact fewer than 500 patients in the United States.
GlobeNewswire Inc. • 3mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT